Phase I clinical trials in adoptive T-cell therapies Journal Article


Authors: Devlin, S. M.; Iasonos, A.; O’Quigley, J.
Article Title: Phase I clinical trials in adoptive T-cell therapies
Abstract: We develop three approaches to phase I dose finding designs for engineered T cells in oncology. Our goal is to address a very particular difficulty in this clinical setting: an inability to fully administer the dose allocated to some patients. Current designs can be biased as a result of this incomplete information being ignored or discarded from the analysis. The performance of the three proposed solutions is largely similar, and all offer an advantage over the currently used design. One of the three methods is supported by theoretical study, and we provide some new results on this approach. © 2021 Royal Statistical Society
Journal Title: Journal of the Royal Statistical Society Series C - Applied Statistics
Volume: 70
Issue: 4
ISSN: 0035-9254
Publisher: Wiley Blackwell  
Date Published: 2021-08-01
Start Page: 815
End Page: 834
Language: English
DOI: 10.1111/rssc.12485
PROVIDER: scopus
PMCID: PMC9400039
PUBMED: 36017232
DOI/URL:
Notes: Article -- Export Date: 1 September 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexia Elia Iasonos
    362 Iasonos
  2. Sean McCarthy Devlin
    601 Devlin